h1

h2

h3

h4

h5
h6
http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png

Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd) : 2-year results from a randomised phase 3 trial

; ; ; ; ; ; ; ; ; ; ;

In
The lancet 402(10405), Seiten/Artikel-Nr.:859-870

ImpressumLondon [u.a.] : Elsevier

ISSN0140-6736

Online
DOI: 10.1016/S0140-6736(23)01554-4


Einrichtungen

  1. Klinik und Lehrstuhl für Innere Medizin (mit dem Schwerpunkt Nephrologie und Immunologie) (531020-2)



Dokumenttyp
Journal Article

Format
online, print

Sprache
English

Anmerkung
Peer reviewed article

Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85169930939
WOS Core Collection: WOS:001080450200001
PubMed: pmid:37591292
OpenAlex: W4385803938

Interne Identnummern
RWTH-CONV-252306
Datensatz-ID: 982225

Beteiligte Länder
Argentina, Canada, Czech Republic, Germany, Peoples R China, Sweden, Turkey, UK, USA

Lizenzstatus der Zeitschrift

 GO


Medline ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 90 ; JCR ; NationallizenzNationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Articles
Faculty of Medicine (Fac.10)
531020\-2
Public records
Publications database

 Record created 2024-03-15, last modified 2026-08-31



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)